Brain

Please click on the protocol number for additional information.

NCCTG N0272: Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

NCCTG N047B: Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCCTG N0572: Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma

NCCTG N0574: Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Please contact the research office for more information.